Abstract
We performed computer simulations to study the effects of prior infection on vaccine efficacy. We injected three antigens sequentially. The first antigen, designated the prior, represented a prior infection or vaccination. The second antigen, the vaccine, represented a single component of the trivalent influenza vaccine. The third antigen, the epidemic, represented challenge by an epidemic strain. For a fixed vaccine to epidemic strain cross-reactivity, we generated prior strains over a full range of cross-reactivities to the vaccine and to the epidemic strains. We found that, for many cross-reactivities, vaccination, when it had been preceded by a prior infection, provided more protection than vaccination alone. However, at some cross-reactivities, the prior infection reduced protection by clearing the vaccine before it had the chance to produce protective memory. The cross-reactivities between the prior, vaccine and epidemic strains played a major role in determining vaccine efficacy. This work has applications to understanding vaccination against viruses such as influenza that are continually mutating.
Original language | English (US) |
---|---|
Pages (from-to) | 363-368 |
Number of pages | 6 |
Journal | Proceedings of the IEEE International Conference on Systems, Man and Cybernetics |
Volume | 1 |
State | Published - Dec 1 1997 |
Externally published | Yes |
Event | Proceedings of the 1997 IEEE International Conference on Systems, Man, and Cybernetics. Part 1 (of 5) - Orlando, FL, USA Duration: Oct 12 1997 → Oct 15 1997 |
ASJC Scopus subject areas
- Control and Systems Engineering
- Hardware and Architecture